![Foto de MARTA](/img/nophoto.png)
MARTA
VAQUERO SUSAGNA
CON
Publicaciones (12) Publicaciones de MARTA VAQUERO SUSAGNA
2024
-
Sprouty1 is a broad mediator of cellular senescence
Cell Death and Disease, Vol. 15, Núm. 4
2023
-
Validation of Modaplex POLE mutation assay in endometrial carcinoma
Virchows Archiv, Vol. 483, Núm. 6, pp. 787-794
2022
-
A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes
Cellular and Molecular Life Sciences, Vol. 79, Núm. 10
2020
-
Intratumour heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification: a descriptive study
Histopathology, Vol. 76, Núm. 3, pp. 447-460
2019
-
Sprouty1 controls genitourinary development via its N-terminal tyrosine
Journal of the American Society of Nephrology, Vol. 30, Núm. 8, pp. 1398-1411
-
Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma
Virchows Archiv, Vol. 474, Núm. 5, pp. 585-598
-
Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis
Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85
2018
-
Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline
Cytotherapy, Vol. 20, Núm. 6, pp. 806-819
2016
-
7-dehydrocholesterol efficiently supports Ret signaling in a mouse model of Smith-Opitz-Lemli syndrome
Scientific Reports, Vol. 6
-
Sprouty1 haploinsufficiency accelerates pheochromocytoma development in Pten+/-mice
Endocrine-Related Cancer
2014
-
Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: Implications for tumorigenesis
Cell Death and Differentiation, Vol. 21, Núm. 2, pp. 333-343
2012
-
Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma
Oncogene, Vol. 31, Núm. 35, pp. 3961-3972